ImpediMed has received $15m in funding for five years from SWK Holdings, which is set to enhance its ability to grow and ...

Be cautious with your favorite pastries this week.

The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...

Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.

New blinded preliminary BRTX-100 data described this past Saturday at prestigious "2025 Winners in Industry Innovations in MSK Health” presentation - - Among other positive preliminary data analyses, ...

FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

February 2025 has already proven to be a busy month in the congressional and US Securities and Exchange Commission public discourse regarding ...

As part of its continued commitment to developing next-generation cancer therapeutics, Ocean Biomedical is initiating ...

The 4th RNA-Targeted Drug Discovery Summit is returning once again this December, to reunite the largest community of thought leaders and experts in biology, chemistry and RNA therapeutics to ...